Lysocap-Forte Tablet, containing Trypsin Chymotrypsin (100000 AU), is a potent proteolytic enzyme formulation indicated for the management of inflammatory conditions and edema associated with trauma, surgery, and infections. Trypsin and chymotrypsin are serine proteases that facilitate the breakdown of proteinaceous debris and fibrin deposits at sites of inflammation, thereby promoting faster resolution of swelling and enhancing tissue repair. This enzyme combination exhibits anti-inflammatory, anti-edematous, and fibrinolytic properties, making it effective in reducing pain and improving functional recovery in musculoskeletal disorders such as sprains, strains, and postoperative inflammation. Lysocap-Forte is also utilized as an adjunct in the treatment of chronic sinusitis, pharyngitis, and other inflammatory conditions where reduction of mucosal edema is beneficial. The tablet is administered orally, with dosage tailored according to the severity of the condition and patient response. It is generally well-tolerated, though caution is advised in patients with hypersensitivity to proteolytic enzymes or bleeding disorders. Concurrent use with anticoagulants requires careful monitoring due to potential additive effects. Lysocap-Forte should be used under medical supervision to ensure optimal therapeutic outcomes and minimize adverse effects.